31 July 2026 June 2026 Quarterly Update Highlights • Libbo® pilot study progressed , with the final study protocol executed and the contract research organisation and clinical site engaged for EVE's vardenafil oral soluble film for the treatment of erectile dysfunction. • ...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- Eve Initiates Pilot Clinical Study for Libbo ED Film
- Appointment of Chief Executive Officer
- Investor Presentation
- Prospectus
- EVE Placement Update
Later from EVE Health
- Quarterly Activities/Appendix 4C Cash Flow Report - Amended
- Appendix 4E
- Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
- Release of Securities from Escrow
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health